A detailed history of Sands Capital Ventures, LLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Sands Capital Ventures, LLC holds 2,122,605 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,122,605
Previous 2,122,605 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
N/A
470,000 Added 28.44%
2,122,605 $0
Q4 2022

Feb 13, 2023

BUY
N/A
1,652,605 New
1,652,605 $19 Million

Others Institutions Holding ACRV

About Acrivon Therapeutics, Inc.


  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Sands Capital Ventures, LLC Portfolio

Follow Sands Capital Ventures, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Ventures, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Ventures, LLC with notifications on news.